Tech Updates
Nov 15, 2025
News
Holo Raises €1M to Bring Preventive Medicine to Consumer Scale
NewDecoded
3 min read
Image by Holo
Spanish healthtech startup Holo has closed a €1 million pre-seed round to scale its all-in-one preventive health platform. The funding round was led by European fund Calm/Storm Ventures and Spanish firm Mission VC, with participation from ENISA and notable business angels including Magnific AI founders Javier López and Emilio Nicolás, alongside executives from Google, Factorial, and Carto. Founded in October 2024 by three former Factorial employees (Francesc Navarro, Emilio Rodríguez, and Sergio Mosquera), Holo consolidates fragmented health data into a single platform. Users can track over 110 biomarkers through annual blood panels, connect wearables like Apple Watch and Oura, and receive personalized reports reviewed by physicians specialized in longevity medicine. The service starts at €199 annually, positioning preventive care at a consumer-accessible price point.
"Health should be something we understand, not something we go blindly into until something goes wrong. At Holo, we want everyone to have control over their well-being as easily as they track their finances," says CEO Francesc Navarro.
The platform creates dynamic health maps covering inflammation markers, hormones, and longevity indicators, helping users anticipate health risks before symptoms appear. Rather than providing medical services directly, Holo operates as a facilitator connecting users with independent laboratories and healthcare providers, reducing regulatory complexity while maintaining clinical quality.
The capital will strengthen Holo's position in Spain while preparing for European expansion in 2026. The company plans to invest in product development, new medical integrations, and clinical partnerships across Europe. Holo is also developing complementary longevity programs to reinforce its vision of becoming Europe's leading preventive health platform.
The founding team's experience scaling Factorial, one of Europe's tech unicorns, informed their approach to building health infrastructure. "We learned how to scale product, culture, and technology from Barcelona. Now, we want to use that knowledge to reshape how we think about health and well-being," Navarro explains.
Holo's €1 million raise signals growing investor confidence in consumer-facing preventive health platforms, particularly in Europe where regulatory frameworks are evolving to accommodate digital health innovation. The positioning as "the Revolut of health" reflects a broader trend of applying fintech-style accessibility to healthcare, moving beyond niche biohacking communities to mainstream adoption.
With aging populations across Europe driving demand for proactive health management and wearable technology reaching maturity, the timing appears strategic. The involvement of high-profile Spanish tech angels and ENISA's participation suggests that Spain is positioning itself as a European healthtech hub, following the success of Barcelona unicorns like Factorial. However, Holo faces the challenge of scaling across Europe's fragmented healthcare systems while maintaining the delicate balance between medical credibility and consumer simplicity that will define the next generation of preventive health platforms.
